Basic info
Industry
biotechnology research
Sectors
Biotechnology
Gene Therapy
Cell Therapy
Spinal Muscular Atrophy
Health Care
Therapeutics
Liver-directed Diseases
AAV
CNS Diseases
Lentivirus
Hemophilia
Eye Diseases
Manufacturing
Date founded
2019
Funding rounds raised
Total raised
$10M
from 7 investors over 7 rounds
E
Exegenesis Bio Inc. raised undisclosed on February 2, 2021
Investors: Hillhouse Capital Management, 凯泰资本, Legend Capital, 博远资本 and LYFE Capital
E
Exegenesis Bio Inc. raised $10M on October 21, 2019
Investors: K2VC 险峰 and 凯泰资本